Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Market Cap	154.38M -41.0%
Revenue (ttm)	1.05B -8.1%
Net Income	-60.91M
EPS	-0.04
Shares Out	1.68B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,000
Open	0.0920
Previous Close	0.0920
Day's Range	0.0920 - 0.0920
52-Week Range	0.0860 - 0.1790
Beta	-0.08
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. It operates through two segments, Manufacturing and Selling of medicines and medical devices; and Sales and Distribution of medicines and healthcare products, and medical devices. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,321
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8329

Financial Performance

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 9, 2026

Data Sources Report a data error